INSUBCONTINENT EXCLUSIVE:
New Delhi: Drug major Cipla on Thursday revealed the commercialisation of its RT-PCR test set 'ViraGen' for COVID-19 in India, in
collaboration with Ubio Biotechnology Systems
This launch will help address the present testing services and capability problems while reaffirming the business's continuous growth in the
diagnostic area, Cipla said in a regulatory filing
Cipla will release ViraGen test kit in the country in collaboration with Ubio Biotechnology Systems, the business stated.The company will
commence supply of the COVID-19 infection detection kit from May 25, 2021
Umang Vohra, MD and Worldwide CEO, Cipla, stated, Cipla has been working relentlessly to ensure accessibility to treatments in this fight
Guided by our core function of 'Taking care of Life', this partnership will allow us to reach out to more people throughout the nation at a
ViraGen is Cipla's third offering in the COVID-19 testing section
